Atosiban is a synthetic nonapeptide studied in laboratory research as a competitive antagonist at oxytocin and vasopressin V1a receptors in vitro. This article summarizes its structure and how researchers characterize it in controlled laboratory settings.

Structure: Atosiban is a modified oxytocin analogue with a deaminated cysteine and substitutions that alter receptor binding in assay systems. Researchers confirm identity and purity by HPLC and mass spectrometry and review the lot-matched Certificate of Analysis before use in experiments.

Laboratory applications: In cell culture and receptor-binding assays, atosiban is used as a pharmacological tool to probe oxytocin/vasopressin signaling pathways. Study designs typically include vehicle controls, concentration-response characterization in the assay system, and analytical verification of the test article. No conclusions about human use can be drawn from in vitro work.

Analytical notes: Store lyophilized material as directed on the product label, protect from moisture, and document lot numbers in laboratory records.

Disclaimer: This product and this article are for laboratory research purposes only. Not for human consumption. Not for medical, therapeutic, diagnostic, or veterinary use. No dosing, reconstitution-for-use, or efficacy information is provided or implied.

Citations: Goodwin et al., oxytocin antagonist pharmacology literature; manufacturer analytical methods for HPLC/MS peptide characterization.